An investigator-initiated Phase 1/2 trial of CNTY-101, an investigational therapy, has been announced for the treatment of ...

A new study found that low or absent disease activity, hydroxychloroquine (HCQ) use, and gradual reduction of GC dosing can ...

EULAR/ACR SLE classification criteria were not linked to mortality or hospitalization, a developed ominosity model adequately predicted mortality.

Results showed that systemic lupus carries the greatest risk for heart health, more than doubling a person’s risk of heart ...

DEAR DR. ROACH: I am a 77-year-old female. After experiencing hair thinning for over a year, I was diagnosed with incomplete lupus by a rheumatologist. My blood markers were high, but I don’t ...

Did you know Selena Gomez went public with her condition right after being diagnosed with lupus? Read on for the details!

Lupus is a chronic disease that can cause inflammation and pain in any part of the body. It’s an autoimmune disease, which ...

Children with lupus nephritis who receive belimumab achieve treatment targets faster, and can taper glucocorticoids earlier, than those using standard immunotherapy, according to data published in ...

Cutaneous lupus erythematosus is associated with an increased risk for ASCVD, similar to the risk seen in association with SLE.

A recent study by Emory University researchers provides new insights into why the mRNA vaccines developed to fight COVID-19 in 2021 are less effective in patients with autoimmune diseases.

Individuals with cutaneous lupus erythematosus have an increased ASCVD risk when compared with those without cutaneous lupus erythematosus.

Systemic lupus erythematosus (SLE) is an autoimmune disease that can be seen in children as well as adults. In children, it is called childhood-onset lupus, pediatric SLE, or juvenile lupus.